GRANISETRON HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Granisetron Hydrochloride, and when can generic versions of Granisetron Hydrochloride launch?
Granisetron Hydrochloride is a drug marketed by Am Regent, Amneal, Baxter Hlthcare Corp, Bionpharma, Dr Reddys, Epic Pharma Llc, Eugia Pharma, Fresenius Kabi Usa, Hikma, Hikma Farmaceutica, Mylan Asi, Mylan Labs Ltd, Rising, Sandoz, Sandoz Inc, Teva Pharms Usa, Wockhardt Usa, Yung Shin Pharm, Apotex Inc, Aurobindo Pharma Usa, Barr, Chartwell Molecular, Dr Reddys Labs Ltd, Natco Pharma, Orbion Pharms, Taro, and Teva Pharms. and is included in forty-six NDAs.
The generic ingredient in GRANISETRON HYDROCHLORIDE is granisetron hydrochloride. There are twenty-six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the granisetron hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Granisetron Hydrochloride
A generic version of GRANISETRON HYDROCHLORIDE was approved as granisetron hydrochloride by AMNEAL on December 31st, 2007.
Summary for GRANISETRON HYDROCHLORIDE
Recent Clinical Trials for GRANISETRON HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 4 |
Guangxi Medical University | Phase 3 |
Heron Therapeutics | Phase 4 |
Pharmacology for GRANISETRON HYDROCHLORIDE
Drug Class | Serotonin-3 Receptor Antagonist |
Mechanism of Action | Serotonin 3 Receptor Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for GRANISETRON HYDROCHLORIDE
Paragraph IV (Patent) Challenges for GRANISETRON HYDROCHLORIDE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
KYTRIL | Injection | granisetron hydrochloride | 0.1 mg/mL, 1 mL single dose vial | 020239 | 1 | 2007-03-08 |
KYTRIL | Injection | granisetron hydrochloride | 1 mg/mL, 4 mL multi-dose vials | 020239 | 1 | 2004-07-19 |
KYTRIL | Injection | granisetron hydrochloride | 1 mg/mL, 1 mL vials | 020239 | 1 | 2004-06-01 |
US Patents and Regulatory Information for GRANISETRON HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Yung Shin Pharm | GRANISETRON HYDROCHLORIDE | granisetron hydrochloride | INJECTABLE;INJECTION | 202647-001 | Mar 6, 2020 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sandoz | GRANISETRON HYDROCHLORIDE | granisetron hydrochloride | INJECTABLE;INJECTION | 078808-001 | Apr 29, 2008 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Epic Pharma Llc | GRANISETRON HYDROCHLORIDE | granisetron hydrochloride | TABLET;ORAL | 078260-001 | Dec 31, 2007 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |